Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.41B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 6.79M
Average 5.33M
ALHC Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Alignment Healthcare, Inc.NASDAQ: ALHC
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 216.3% from a year ago
Cash & equivalents stood at $1.41B at the end of Q1 FY2026, up 216.3% from a year earlier and up 144.2% from the prior quarter. Over 3 fiscal years it compounded at +12.2% a year.
Context
- Cash & equivalents amounted to 111.9% of total assets at the end of Q1 FY2026, up 62.0 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +216.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 577.94M USD
- Year-over-year change
- +33.5%
- 4-year CAGR
- +5.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 577.94M | +33.5% |
| FY2024 | 2024-12-31 | 432.86M | +113.3% |
| FY2023 | 2023-12-31 | 202.9M | -50.5% |
| FY2022 | 2022-12-31 | 409.55M | -12.2% |
| FY2021 | 2021-12-31 | 466.6M | — |
Cash & Equivalents vs competitors
How ALHC compares with its peers on the latest reported figures
- ALHC's Mar 2026 cash & equivalents of $1.41B is the lowest of the 7 companies compared; the peer median is $8.64B.
- Its year-over-year change of +216.3% is the highest of 7, against a peer median of +23.7%.
- Cash & equivalents amounts to 111.9% of total assets for ALHC, versus a peer median of 20.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $25.85B | -5.0% | +1.4% | 8.3% | |
| Jun 2026 | $24.15B | +66.4% | +14.0% | 29.1% | |
| Sep 2026 | $10.35B | +18.8% | +8.7% | 8.1% | |
| Sep 2026 | $6.94B | +28.7% | -6.0% | 12.1% | |
| Sep 2026 | $4.48B | +6.1% | +2.0% | 28.6% | |
| Jun 2026 | $4.08B | +56.8% | +21.2% | 36.3% | |
| Mar 2026 | $1.41B | +216.3% | +12.2% | 111.9% | |
| Peer median (excluding ALHC) | $8.64B | +23.7% | +5.3% | 20.4% | |
Competitors are the stored peer set for ALHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 466.6M | 409.55M | 202.9M | 432.86M | 577.94M |
| Short-term Investments | 0 | 0 | 115.91M | 37.79M | 0 |
| Net Receivables | 58.51M | 92.89M | 119.75M | 153.9M | 253.21M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 42.11M | 44.97M | 37.08M | 0 |
| Total Current Assets | 552.86M | 544.55M | 483.54M | 661.64M | 831.14M |
| Property, Plant & Equipment (Net) | 38.21M | 42.99M | 61.86M | 74.96M | 71.27M |
| Goodwill | 29.3M | 34.81M | 34.83M | 34.83M | 32.06M |
| Intangible Assets | 5.81M | 5.48M | 5.25M | 4.55M | 4.55M |
| Long-term Investments | 0 | 0 | 0 | 0 | 28.41M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.71M | 6.04M | 6.41M | 6.09M | 98.35M |
| Total Non-current Assets | 78.04M | 89.32M | 108.34M | 120.43M | 234.64M |
| Total Assets | 630.9M | 633.86M | 591.88M | 782.06M | 1.07B |
| Account Payables | 17.43M | 171.92M | 170.07M | 242.5M | 474.57M |
| Short-term Debt | 0 | 0 | 0 | 1.21M | 1.96M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 34.11M | 38.72M | 0 |
| Total Current Liabilities | 167.25M | 229.96M | 263.02M | 351.85M | 476.53M |
| Long-term Debt | 150.62M | 160.9M | 161.81M | 321.43M | 323.18M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 73.87M |
| Total Non-current Liabilities | 157.6M | 164.6M | 170.79M | 329.26M | 409.98M |
| Total Liabilities | 324.84M | 394.56M | 433.81M | 681.11M | 886.51M |
| Common Stock | 187K | 187K | 189K | 192K | 205K |
| Retained Earnings | (582.69M) | (732.24M) | (880.26M) | (1.01B) | (1.01B) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 15K | 1.18M | 1.13M | 1.1M | 0 |
| Total Equity | 306.06M | 239.3M | 158.07M | 100.96M | 179.28M |
| Total Debt | 157.6M | 164.6M | 170.79M | 329.26M | 338.07M |
| Net Debt | (309.01M) | (244.95M) | (32.12M) | (103.6M) | (239.87M) |
Alignment Healthcare, Inc.
NASDAQ:ALHC
Intrinsic Alpha fair value
Locked
Current Price
$6.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.